PLIN3

Perilipin-3 · O60664 · PLIN3 on Sugi Atlas →

0 patent compounds predicted against PLIN3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PLIN3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes PHASE4COMPLETED
Effect of Nicotinic Acid on Adipose Tissue Inflammation in Obese Subjects PHASE2COMPLETED
Cholic Acid for Hepatic Steatosis in Lipodystrophy PHASE2COMPLETED
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides PHASE1COMPLETED
Insulin Regulation of Lipolysis and Lipolysis Proteins EARLY_PHASE1RECRUITING
Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism EARLY_PHASE1COMPLETED
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Mitochondrial Activity and Myosteatosis in the Cachexia of Cancers of the Upper Aerodigestive Tract nanUNKNOWN
Evaluation of Risk of hEpatocellular Carcinoma nanRECRUITING
Association of Genes to Resistance to Weight Loss in Obese Patients nanCOMPLETED
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
MARS: Magnetic Resonance Study: A Novel Assessment of Placental Function nanCOMPLETED
Familial Partial Lipodystrophy Study nanCOMPLETED
Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy nanCOMPLETED
Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease nanNOT_YET_RECRUITING
Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease nanUNKNOWN
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects nanUNKNOWN
The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD. nanENROLLING_BY_INVITATION
The Role of Ectopic Fat and Heart Attack Risk in HIV nanRECRUITING
Liver Fat as a Dietary Target for Treating Cardiometabolic Disorders in Prediabetes and Type 2 Diabetes nanCOMPLETED
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study nanCOMPLETED
for Adipose Tissue DIabetes VAriants (fATDIVA) nanCOMPLETED
Identification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With Classic Polycystic Ovary Syndrome (PCOS) nanNOT_YET_RECRUITING
Omega-3 vs Very Low Calorie Diet for Liver Size Reduction nanUNKNOWN
Peking University & University of Michigan Study of MI and Atherosclerosis nanCOMPLETED
Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Risk of Progression Towards DIABETES and Development of Complications. LIPINFAT Diabetes Study. nanRECRUITING
Regulation Of Maternal Fuel Supply And Neonatal Adiposity nanCOMPLETED
Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea nanCOMPLETED
Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome. nanCOMPLETED
Human Liver ORganoids as a Model to Study the Development of Non-Alcoholic SteatOhepatitis (NASH) nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a PLIN3 binder may also engage these)

ProteinNameSimilarity
Q5RAV8 1.000 Q5RAV8 →
Q5BLZ2 1.000 Q5BLZ2 →
Q9TUM6 0.998 Q9TUM6 →
Q9DBG5 0.997 Q9DBG5 →
P43883 0.997 P43883 →
Q99541 0.994 Q99541 →
Q4PLW0 0.992 Q4PLW0 →
A6QLL0 0.984 A6QLL0 →
Q8BVZ1 0.981 Q8BVZ1 →
Q9MA63 0.974 Q9MA63 →
M0R7Z9 0.973 M0R7Z9 →
B0FJL7 0.973 B0FJL7 →
A2Y0H2 0.970 A2Y0H2 →
Q9SW70 0.969 Q9SW70 →
PLIN5 Perilipin-5 (Lipid storage droplet protein 5) 0.969 landscape →
PLIN1 Perilipin-1 0.966 landscape →
Q9FRA7 0.964 Q9FRA7 →
P0DTU8 0.964 P0DTU8 →
Q9LFD5 0.964 Q9LFD5 →
P18658 0.963 P18658 →
P0DKU5 0.963 P0DKU5 →
P0DKY1 0.963 P0DKY1 →
O82803 0.963 O82803 →
Q41112 0.962 Q41112 →
G3V8D4 0.962 G3V8D4 →
A0A2Y9HRR8 0.962 A0A2Y9HRR8 →
P0DTV2 0.961 P0DTV2 →
P0DMA9 0.961 P0DMA9 →
P0DTR9 0.960 P0DTR9 →
A0A0D9S1R9 0.960 A0A0D9S1R9 →